computer generated concept art Dear Subscribers:
Solar-powered OAK charging stations will bring depression, anxiety, and insomnia treatment to places where no other mental healthcare exists—no cell phone or electrical grid needed.
Fisher Wallace and its thousands of individual investors are building this future.
Our devices have already been deployed in Ukraine across three hospitals: fewer than 20 devices being used around the clock to treat hundreds of soldiers and civilians with PTSD. The doctors reportedthat our technology, combined with their standard of care, performed dramatically better than their standard of care alone: higher overall improvement (79.8% vs. 49.4%), faster anxiety/depression reduction (76.9% vs. 48%), and far greater sleep-wake normalization (89.3% vs. 31.5%).
Since January, our devices have been deployed in a feasibility study at the US Department of Veterans Affairs to treat US military veterans. Following FDA clearance, and in partnership with our veteran-owned sales and distribution partners, we intend to scale across all VA medical centers.
Our current crowdfunding campaign is crucial for preparing OAK to go to market. We are a few months away from the first of multiple FDA clearance decisions we are seeking. If you've invested before, I respectfully ask that you double down. If you haven't invested yet, I invite you to participate in this endeavor as a part-owner. If you purchase $113+ in equity, you will receive 100% bonus shares (ie, buy 100 shares, receive 200 shares in total). We expect this to be the last campaign we run prior to FDA clearance. Thank you for your consideration!
Kelly Roman
Co-Founder and CEO
Fisher Wallace Labs
|
